Mevalonic acid (lithium salt)

Catalog Number Pack Size List Price* Quantity
HY-113071A-5MG 5 mg 257,00 Add
HY-113071A-1ML 10mM/1mL 282,00 Add
HY-113071A-50MG 50 mg 593,00 Add
HY-113071A-100MG 100 mg 1'109,00 Add
HY-113071A-250MG 250 mg 2'013,00 Add
HY-113071A-500MG 500 mg 3'305,00 Add

* CHF, excl. 7.7% VAT and shipping costs

Product Description

35% discount on MedChem product orders above CHF 1'000 !
- 1st November - 31st December 2023
- Not cumulative with the "30% off Screening Libraries Promotion"

MVA (lithium salt)
Mevalonic acid (MVA) lithium salt is a precursor substance of the mevalonate pathway, which is essential for cell growth and proliferation. Mevalonic acid lithium salt is effective in inhibiting Simvastatin (HY-17502)-induced decrease in C2C12 cell viability in vitro. Mevalonic acid lithium salt can be used in studies of myopathy and heart failure[1][2].

Category Biochemicals
Supplier MedChem Express
Regulatory Status RUO
Research Field Metabolic Disease, Neurological Disease, Cardiovascular Disease, Metabolic Enzyme/Protease
Format Solubility: DMSO : 50 mg/mL (ultrasonic);H2O : 100 mg/mL (ultrasonic)
Grade Clinical information: Phase 3
Purity 98%
Molecular Formula C6H11LiO4
Molecular Weight 154.09
CAS-Number 2618458-93-6
Storage Conditions 4°C (Powder, sealed storage, away from moisture)
Tech. Data Sheet View datasheet
Link To Supplier
Shipping Details Room Temperature
Material Safety Data Sheet Download PDF